Citadel Advisors
NVRO

Citadel Advisors’s NEVRO CORP. NVRO Stock Holding History

Citadel Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,700
Closed -$279K – 15779
2025
Q1 		$279K Sell
47,700
-82,400
-63% -$434K ﹤0.01% 9765
2024
Q4 		$484K Buy
130,100
+80,200
+161% +$370K ﹤0.01% 8633
2024
Q3 		$279K Buy
49,900
+23,200
+87% +$162K ﹤0.01% 9483
2024
Q2 		$225K Sell
26,700
-1,900
-7% -$20.3K ﹤0.01% 9687
2024
Q1 		$413K Sell
28,600
-17,200
-38% -$284K ﹤0.01% 8802
2023
Q4 		$986K Sell
45,800
-11,900
-21% -$212K ﹤0.01% 6713
2023
Q3 		$1.11M Sell
57,700
-35,300
-38% -$753K ﹤0.01% 6349
2023
Q2 		$2.36M Buy
93,000
+54,600
+142% +$1.58M ﹤0.01% 4858
2023
Q1 		$1.39M Buy
38,400
+700
+2% +$24.6K ﹤0.01% 6065
2022
Q4 		$1.49M Sell
37,700
-26,000
-41% -$1.08M ﹤0.01% 6042
2022
Q3 		$2.97M Sell
63,700
-2,000
-3% -$92.8K ﹤0.01% 4831
2022
Q2 		$2.88M Sell
65,700
-1,200
-2% -$66K ﹤0.01% 4835
2022
Q1 		$4.84M Buy
66,900
+46,600
+230% +$3.36M ﹤0.01% 4230
2021
Q4 		$1.65M Sell
20,300
-24,300
-54% -$2.44M ﹤0.01% 6681
2021
Q3 		$5.19M Buy
44,600
+22,600
+103% +$2.96M ﹤0.01% 4228
2021
Q2 		$3.65M Buy
22,000
+12,600
+134% +$1.97M ﹤0.01% 5148
2021
Q1 		$1.31M Sell
9,400
-4,200
-31% -$685K ﹤0.01% 7442
2020
Q4 		$2.35M Sell
13,600
-6,100
-31% -$988K ﹤0.01% 5020
2020
Q3 		$2.74M Buy
19,700
+4,600
+30% +$615K ﹤0.01% 4129
2020
Q2 		$1.8M Sell
15,100
-3,900
-21% -$463K ﹤0.01% 4766
2020
Q1 		$1.9M Sell
19,000
-21,900
-54% -$2.63M ﹤0.01% 4222
2019
Q4 		$4.81M Sell
40,900
-20,000
-33% -$1.98M ﹤0.01% 3132
2019
Q3 		$5.24M Buy
60,900
+50,700
+497% +$3.84M ﹤0.01% 3047
2019
Q2 		$661K Sell
10,200
-13,900
-58% -$865K ﹤0.01% 6375
2019
Q1 		$1.51M Sell
24,100
-200
-0.8% -$9.4K ﹤0.01% 4910
2018
Q4 		$945K Sell
24,300
-10,300
-30% -$458K ﹤0.01% 5402
2018
Q3 		$1.97M Buy
34,600
+14,700
+74% +$919K ﹤0.01% 4427
2018
Q2 		$1.59M Buy
19,900
+11,000
+124% +$912K ﹤0.01% 4455
2018
Q1 		$771K Sell
8,900
-7,200
-45% -$581K ﹤0.01% 5202
2017
Q4 		$1.11M Buy
16,100
+900
+6% +$72K ﹤0.01% 4514
2017
Q3 		$1.38M Buy
15,200
+3,700
+32% +$317K ﹤0.01% 3873
2017
Q2 		$856K Sell
11,500
-19,000
-62% -$1.52M ﹤0.01% 4317
2017
Q1 		$2.86M Buy
30,500
+14,400
+89% +$1.3M ﹤0.01% 2641
2016
Q4 		$1.17M Sell
16,100
-300
-2% -$25.7K ﹤0.01% 3653
2016
Q3 		$1.71M Sell
16,400
-500
-3% -$45.2K ﹤0.01% 3152
2016
Q2 		$1.25M Sell
16,900
-5,900
-26% -$400K ﹤0.01% 3301
2016
Q1 		$1.28M Buy
22,800
+13,000
+133% +$767K ﹤0.01% 3169
2015
Q4 		$662K Buy
9,800
+6,800
+227% +$364K ﹤0.01% 4105
2015
Q3 		$139K Buy
+3,000
New +$145K ﹤0.01% 6594

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's NVRO Position: Q2 2025 in Review

Citadel Advisors sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 6,032 shares — an estimated $35.2K sold.

Citadel Advisors first reported a position in NVRO in Q4 2014 and held it in 40 quarters. The position peaked at $93.8M in Q3 2017. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Citadel Advisors reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 6,032 NEVRO CORP. shares in Q2 2025, an estimated $35.2K.
  • Citadel Advisors first reported a position in NEVRO CORP. in Q4 2014 and held it in 40 quarters.
  • Citadel Advisors's NEVRO CORP. position peaked at $93.8M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.